Evidence map›Paper›PMID 37857762›Full record

Trial reportScientific reports2023

Community evaluation of VECTRON™ T500, a broflanilide insecticide, for indoor residual spraying for malaria vector control in central Benin; a two arm non-inferiority cluster randomised trial.

Corine Ngufor, Renaud Govoetchan, Augustin Fongnikin, Corneille Hueha, Juniace Ahoga, Thomas Syme, Abel Agbevo, Abdoulaye Daleb, Graham Small, Derric Nimmo and 6 more

Open access · goldAbstract readEquivalence TrialRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Corine NguforLondon School of Hygiene and Tropical Medicine (LSHTM), London, WC1E 7HT, UK. corine.ngufor@lshtm.ac.uk.
Renaud GovoetchanLondon School of Hygiene and Tropical Medicine (LSHTM), London, WC1E 7HT, UK.
Augustin FongnikinCentre de Recherches Entomologiques de Cotonou (CREC), Cotonou, Benin.
Corneille HuehaCentre de Recherches Entomologiques de Cotonou (CREC), Cotonou, Benin.
Juniace AhogaCentre de Recherches Entomologiques de Cotonou (CREC), Cotonou, Benin.
Thomas SymeLondon School of Hygiene and Tropical Medicine (LSHTM), London, WC1E 7HT, UK.
Abel AgbevoLondon School of Hygiene and Tropical Medicine (LSHTM), London, WC1E 7HT, UK.
Abdoulaye DalebCentre de Recherches Entomologiques de Cotonou (CREC), Cotonou, Benin.
Graham SmallInnovative Vector Control Consortium, Liverpool, UK.
Derric NimmoInnovative Vector Control Consortium, Liverpool, UK.
John BradleyLondon School of Hygiene and Tropical Medicine (LSHTM), London, WC1E 7HT, UK.
Rock AikponNational Malaria Control Programme, Ministry of Health, Cotonou, Benin.
Laurent IyikirengaPMI VectorLink, ABT Associates, Cotonou, Benin.
Razaki OsseCentre de Recherches Entomologiques de Cotonou (CREC), Cotonou, Benin.
Filemon TokponnonCentre de Recherches Entomologiques de Cotonou (CREC), Cotonou, Benin.
Germain Gil PadonouCentre de Recherches Entomologiques de Cotonou (CREC), Cotonou, Benin.
London School of Hygiene & Tropical Medicine · GBInnovative Vector Control Consortium · GBAbt Associates (Nepal) · NP

Funding

Medical Research Council MR/R010161/1
6 · The paper itself

Abstract

VECTRON™ T500 is a wettable powder IRS formulation of broflanilide, a newly discovered insecticide. We performed a two-arm non-inferiority community randomised evaluation of VECTRON™ T500, compared to Fludora® Fusion against pyrethroid-resistant Anopheles gambiae s.l. in an area of high coverage with pyrethroid-only nets in the Za-Kpota District of central Benin. One round of IRS was applied in all consenting households in the study area. Sixteen clusters were randomised (1:1) to receive VECTRON™ T500 (100 mg/m

Indexed as

AnophelesInsecticidesMalariaPyrethrinsAnimalsBeninBenzamidesFemaleFluorocarbonsGuanidinesHumansInsecticide ResistanceMosquito ControlMosquito VectorsNeonicotinoidsThiazoles3-benzamido-N-(4-(perfluoropropan-2-yl)phenyl)benzamideBenzamidesclothianidinFluorocarbonsGuanidinesInsecticidesNeonicotinoidsPyrethrinsThiazoles

Identifiers

PMID37857762
PMCPMC10587144
OpenAlexW4387781310

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.